Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 10 | $51,815 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 Jan 2024 17:30 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 17 Jan 2024 | Sale | 12,805 | 0.673 | 8,618 | D |
17 Jan 2024 17:30 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 16 Jan 2024 | Sale | 4,681 | 0.79 | 3,698 | D |
17 Jan 2024 17:30 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 17 Jan 2024 | Sale | 5,309 | 0.673 | 3,573 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 11 Jan 2024 | Sale | 4,009 | 0.8367 | 3,354 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 12 Jan 2024 | Sale | 5,220 | 0.8541 | 4,458 | D |
01 Aug 2023 17:00 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 01 Aug 2023 | Sale | 3,096 | 0.9056 | 2,804 | D |
17 Jan 2023 21:17 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 17 Jan 2023 | Sale | 4,440 | 1.858 | 8,250 | D |
12 Jan 2023 21:02 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 12 Jan 2023 | Sale | 4,973 | 1.706 | 8,484 | D |
12 Jan 2023 21:02 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 11 Jan 2023 | Sale | 3,843 | 1.7468 | 6,713 | D |
04 Jan 2023 21:01 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 04 Jan 2023 | Sale | 1,100 | 1.694 | 1,863 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)